PCM
DRTSW icon

Prelude Capital Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Prelude Capital Management’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,225
Closed -$5K – 1392
2022
Q3 		$5K Hold
11,225
– – ﹤0.01% 1357
2022
Q2 		$5K Hold
11,225
– – ﹤0.01% 1639
2022
Q1 		$7K Buy
+11,225
New +$6.12K ﹤0.01% 1635

Other funds holding DRTSW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Prelude Capital Management's DRTSW Position: Q4 2022 in Review

Prelude Capital Management sold out of Alpha Tau Medical Warrant (DRTSW) in Q4 2022, closing a stake of 11,225 shares — an estimated $5K sold.

Prelude Capital Management first reported a position in DRTSW in Q1 2022 and held it in 3 quarters. The position peaked at $7K in Q1 2022. 34 funds tracked by Wall St. Rank hold DRTSW as of Q4 2022.

  • Prelude Capital Management reported no remaining Alpha Tau Medical Warrant position as of Q4 2022 after selling out during the quarter.
  • Prelude Capital Management sold 11,225 Alpha Tau Medical Warrant shares in Q4 2022, an estimated $5K.
  • Prelude Capital Management first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 3 quarters.
  • Prelude Capital Management's Alpha Tau Medical Warrant position peaked at $7K in Q1 2022.
  • 34 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.